A comparison of diverticulitis in Crohn's disease versus ulcerative colitis

被引:2
|
作者
Persaud, Alana [1 ]
Ahmed, Ahmed [1 ]
Kakked, Gaurav [3 ]
Shulik, Oleg [2 ]
Ahlawat, Sushil [2 ]
机构
[1] Rutgers New Jersey Med Sch, Div Med, Newark, NJ USA
[2] Rutgers New Jersey Med Sch, Div Gastroenterol & Hepatol, Newark, NJ USA
[3] Mt Sinai West St Lukes Roosevelt, Div Med, New York, NY USA
来源
JGH OPEN | 2019年 / 3卷 / 06期
关键词
Crohn's disease; diverticulitis; inflammatory bowel disease; ulcerative colitis; INFLAMMATORY-BOWEL-DISEASE; COLONIC DIVERTICULOSIS; NATURAL-HISTORY; PATTERNS; PREVALENCE; COST;
D O I
10.1002/jgh3.12192
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aim Inflammatory bowel disease (IBD) and diverticulitis both increase morbidity, especially when associated with in-patient hospitalization. This study aimed to evaluate whether hospitalization burden differs for diverticulitis in patients with a history of Crohn's disease (CD) compared to ulcerative colitis (UC). Method All patients hospitalized for acute diverticulitis with pre-existing UC or CD in 2014 were selected using the national in-patient sample. Cases were identified using the International Classification of Diseases, Ninth Edition codes. Primary outcomes were mortality, cost of admission, length of stay (LOS), and colectomy. Results A total of 1815 patients were admitted with diverticulitis, and those with CD had a hospitalization associated with decreased cost (aOR -14 537, 95% CI -27 316 to -1758; P = 0.026) and LOS (aOR -1.31, 95% CI -2.41 to -0.208; P = 0.02) compared to UC. A second analysis comparing diverticulitis hospitalization between those with CD and those with the absence of IBD showed no significant difference in mortality (aOR 2.47, 95% CI 0.59 to 10.36; P = 0.22), LOS (aOR 0.03, 95% CI -0.47 to 0.54; P = 0.92), or cost of admission (aOR -2196, 95% CI -6933 to 2539; P = 0.36) between the cohorts. Conclusion Patients with UC have worsened hospitalization outcomes when being treated for diverticulitis compared to CD. While the findings may be a result of a difference in colectomy rates, the etiology may also be multifactorial. These conclusions have not been previously described, and further investigations would better characterize these associations.
引用
收藏
页码:508 / 512
页数:5
相关论文
共 50 条
  • [21] Metaproteomics of fecal samples of Crohn's disease and Ulcerative Colitis
    Lehmann, T.
    Schallert, K.
    Vilchez-Vargas, R.
    Benndorf, D.
    Puettker, S.
    Sydor, S.
    Schulz, C.
    Bechmann, L.
    Canbay, A.
    Heidrich, B.
    Reichl, U.
    Link, A.
    Heyer, R.
    JOURNAL OF PROTEOMICS, 2019, 201 : 93 - 103
  • [22] Current position on Vedolizumab for ulcerative colitis and Crohn's disease
    Schreiber, S.
    Dignass, A. U.
    Hartmann, H.
    Kruis, W.
    Rogler, G.
    Siegmund, B.
    Stallmach, A.
    Witte, C.
    Bokemeyer, B.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2015, 53 (06): : 591 - 602
  • [23] Diagnosis of Crohn's disease and ulcerative colitis using the microbiome
    Kang, Da-Yeon
    Park, Jong-Lyul
    Yeo, Min-Kyung
    Kang, Sang-Bum
    Kim, Jin-Man
    Kim, Ju Seok
    Kim, Seon-Young
    BMC MICROBIOLOGY, 2023, 23 (01)
  • [24] New biologic therapeutics for ulcerative colitis and Crohn's disease
    Mozaffari, Shilan
    Nikfar, Shekoufeh
    Abdolghaffari, Amir Hossein
    Abdollahi, Mohammad
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (05) : 583 - 600
  • [25] Is there a role for vedolizumab in the treatment of ulcerative colitis and Crohn's disease?
    Gilroy, Leah
    Allen, Patrick B.
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2014, 7 : 163 - 172
  • [26] Differentially Expressed miRNAs in Ulcerative Colitis and Crohn's Disease
    Yarani, Reza
    Shojaeian, Ali
    Palasca, Oana
    Doncheva, Nadezhda T.
    Jensen, Lars Juhl
    Gorodkin, Jan
    Pociot, Flemming
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [27] Safety of vedolizumab in the treatment of Crohn's disease and ulcerative colitis
    Hagan, Matilda
    Cross, Raymond K.
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (09) : 1473 - 1479
  • [28] Crohn's Disease after Proctocolectomy and IPAA for Ulcerative Colitis
    Hercun, Julian
    Cote-Daigneault, Justin
    Lahaie, Raymond G.
    Richard, Carole
    Wassef, Ramses
    Poitras, Pierre
    DISEASES OF THE COLON & RECTUM, 2021, 64 (02) : 217 - 224
  • [29] Evaluation of inflammatory activity in Crohn's disease and ulcerative colitis
    Vilela, Eduardo Garcia
    da Gama Torres, Henrique Osvaldo
    Martins, Fabiana Paiva
    de Abreu Ferrari, Maria de Lourdes
    Andrade, Marcella Menezes
    da Cunha, Aloisio Sales
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (09) : 872 - 881
  • [30] Fracture risk is increased in Crohn's disease, but not in ulcerative colitis
    Vestergaard, P
    Krogh, K
    Rejnmark, L
    Laurberg, S
    Mosekilde, L
    GUT, 2000, 46 (02) : 176 - 181